JP2004292444A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004292444A5 JP2004292444A5 JP2004068260A JP2004068260A JP2004292444A5 JP 2004292444 A5 JP2004292444 A5 JP 2004292444A5 JP 2004068260 A JP2004068260 A JP 2004068260A JP 2004068260 A JP2004068260 A JP 2004068260A JP 2004292444 A5 JP2004292444 A5 JP 2004292444A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- salt
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004068260A JP2004292444A (ja) | 2003-03-13 | 2004-03-11 | 上部消化管疾患の予防・治療剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003068963 | 2003-03-13 | ||
| JP2004068260A JP2004292444A (ja) | 2003-03-13 | 2004-03-11 | 上部消化管疾患の予防・治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004292444A JP2004292444A (ja) | 2004-10-21 |
| JP2004292444A5 true JP2004292444A5 (enExample) | 2007-04-19 |
Family
ID=32984605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004068260A Abandoned JP2004292444A (ja) | 2003-03-13 | 2004-03-11 | 上部消化管疾患の予防・治療剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20070042947A1 (enExample) |
| EP (1) | EP1602380A4 (enExample) |
| JP (1) | JP2004292444A (enExample) |
| WO (1) | WO2004080485A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004106382A1 (ja) | 2003-05-28 | 2004-12-09 | Takeda Pharmaceutical Company Limited | 抗体およびその用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001098494A1 (fr) * | 2000-06-21 | 2001-12-27 | Takeda Chemical Industries, Ltd | Ligand de gpr8 et son adn |
| DE60227519D1 (de) * | 2001-06-14 | 2008-08-21 | Takeda Pharmaceutical | Neuer ligand und dna davon |
| AU2003218713A1 (en) * | 2002-03-22 | 2003-10-08 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7) |
| AU2003212356A1 (en) * | 2002-03-26 | 2003-10-08 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) |
| JP2006513702A (ja) * | 2002-09-09 | 2006-04-27 | ヌラ インコーポレーティッド | Gタンパク質共役受容体およびその使用 |
| WO2004106382A1 (ja) * | 2003-05-28 | 2004-12-09 | Takeda Pharmaceutical Company Limited | 抗体およびその用途 |
-
2004
- 2004-03-11 JP JP2004068260A patent/JP2004292444A/ja not_active Abandoned
- 2004-03-11 EP EP04719631A patent/EP1602380A4/en not_active Withdrawn
- 2004-03-11 US US10/548,817 patent/US20070042947A1/en not_active Abandoned
- 2004-03-11 WO PCT/JP2004/003227 patent/WO2004080485A1/ja not_active Ceased
-
2008
- 2008-06-24 US US12/214,938 patent/US20090227501A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tulipano et al. | Characterisation of the potential of β-lactoglobulin and α-lactalbumin as sources of bioactive peptides affecting incretin function: In silico and in vitro comparative studies | |
| CN105829339B (zh) | 胰高血糖素-glp-1-gip三重激动剂化合物 | |
| TWI689515B (zh) | Gip-glp-1雙重促效劑化合物及方法 | |
| JP2023071932A (ja) | 活性比が最適化されたfgf21化合物/glp-1rアゴニスト組合せ物 | |
| RU2716985C2 (ru) | Соединения-агонисты gip и способы | |
| Ceranowicz et al. | Peptidyl hormones of endocrine cells origin in the gut—Their discovery and physiological relevance | |
| US10961293B2 (en) | Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | |
| JP2020200332A5 (enExample) | ||
| CN1551780A (zh) | 用于预防或治疗体重过重的胃肠激素 | |
| US20140205587A1 (en) | Proteases for Degrading Gluten | |
| O'Harte et al. | Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties | |
| Inoue et al. | Release of cholecystokinin and gallbladder contraction before and after gastrectomy | |
| JP7544838B2 (ja) | 選択的gip受容体アゴニストとしてのペプチド | |
| JP2010504336A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| JP2005513419A5 (enExample) | ||
| CN110691788A (zh) | 长效gip肽类似物 | |
| JP2004292444A5 (enExample) | ||
| RU2007116346A (ru) | Мутированный амилоидный белок | |
| CA2413195A1 (en) | Ligand to gpr8 and dna thereof | |
| Fowler et al. | The cardiovascular response in sepsis: proposed mechanisms of the beneficial effect of adrenomedullin and its binding protein | |
| US20120058948A1 (en) | Collagen peptides as immune modulators | |
| TW201734035A (zh) | 胜肽類似物 | |
| JP2008522632A5 (enExample) | ||
| JP3943459B2 (ja) | アンジオテンシン変換酵素阻害ペプチド |